ALDH1A3 and breast cancer: Together the metabolite profiling, in vivo data, and patient tumor analyses, suggests that GABA is pro-metastatic in breast cancer and GABA metabolism and the signaling pathway is connected to ALDH1A3 in breast cancer cells.